| TOPICAL REVIEW |
Cardiovascular
Infections
Subacute bacterial endocarditis (p. 51)
Acute bacterial endocarditis (p. 53)
Prosthetic valve endocarditis (p. 55)
Pericarditis/myocarditis (p. 56)
IV line and pacemaker infections (p. 57)
Vascular graft infections (p. 60) |
SELF-ASSESSMENT
QUESTIONS: ENDOCARDITIS |
1. Usual subacute bacterial endocarditis (SBE) pathogens include:
a. S. viridans
b. Enterococci (E.
faecalis, E. faecium)
c. E. coli
d. Legionella, Coxiella burnetii, Chlamydia psittaci, Brucella
Make your selection before
scrolling down beyond this point
Answer: Viridans streptococci from the
mouth is responsible for 50-70% of all cases of native valve endocarditis in normal hosts.
Usual endocarditis pathogens following GI and GU procedures are enterococci. Pathogens
causing culture-negative endocarditis, which require specific serology for diagnosis,
include Legionella, Coxiella burnetii, Chlamydia psittaci, and Brucella. E. coli is a
common urinary tract pathogen, but is not a usual cause of SBE. (Answer: all except c)
2. Preferred IV treatment regimens
for SBE include:
a. S.
viridans: Ceftriaxone + gentamicin x
2 weeks
b. E.
faecalis: Vancomycin + gentamicin x 2
weeks
c. E.
faecium: Vancomycin + gentamicin x 4
weeks
d. S.
bovis: Ceftriaxone + gentamicin x 2
weeks
Make your selection
before scrolling down beyond this point
Answer: Preferred IV therapy for S.
viridans SBE is a 2-week course of ceftriaxone 2 gm (IV) q24h plus gentamicin 120 mg (IV)
q24h. For E. faecalis, therapy consists of vancomycin 1 g (IV) q12h plus gentamicin 80 mg
(IV) q8h x 4-6 weeks, not 2 weeks. E. faecium (VRE) is resistant to vancomycin, and should
be treated with linezolid 600 mg (IV) q12h x 4-6 weeks. S. bovis is treated the same as S.
viridans SBE. (Answer: a, d)
3. In patients with S. viridans
SBE:
a. Vegetations and fever without positive
blood cultures or peripheral manifestations of SBE is adequate for the diagnosis
b. Vegetations may persist after antibiotic
therapy, but are sterile
c. It is important to repeat blood cultures
to document clinical
responsiveness, even if the patient defervesces and appears to be
responding clinically
d. A minimum of 4 weeks of antibiotic
therapy is required
Make your selection before
scrolling down beyond this point
Answer: S. viridans endocarditis presents
as a subacute febrile illness " localizing symptoms/signs in a patient with a heart
murmur. Peripheral manifestations (e.g., clubbing, splenomegaly, petechiae) are often
absent with early diagnosis and treatment. Diagnosis is confirmed by positive blood
cultures plus a cardiac vegetation on transthoracic or transesophageal echo; vegetations
without positive blood cultures or peripheral manifestations of SBE are not diagnostic of
endocarditis. Cardiac valve/mural vegetations may persist after antibiotic therapy, but
are sterile. Weekly ESRs should be followed to monitor antibiotic response; repeat blood
cultures are not required unless the patient has persistent fevers or is not responding
clinically. A 2-week course of antibiotics is acceptable for uncomplicated S. viridans
SBE. Prognosis is related to the extent of embolization and severity of heart failure,
although cure rates generally exceed 90%. (Answer: b)
4. All of the following statements
about SBE are true except:
a. S. bovis SBE is often associated with GI
polyp or tumor
b. Enterococcal SBE commonly follows GI/GU
instrumentation
c. Non-enterococcal Group D streptococci
(S. bovis) is penicillin-sensitive, unlike Group D enterococci (E. faecalis)
d. Most cases of
"culture-negative" SBE are not really culture negative, but are due to
fastidious organisms requiring prolonged incubation with enhanced CO2
atmosphere for growth
Make your selection before
scrolling down beyond this point
Answer: The most common SBE pathogens
following GI/GU instrumentation are enterococci, especially E. faecalis. S. bovis is
responsible for 10% of endocarditis cases, and is often associated with colonic polyps
(65%) or malignancy (20%). S. bovis is sensitive to penicillin, unlike E.
faecalis. Most
cases of culture-negative SBE are not really culture negative, but are due to fastidious
organisms (HACEK group), which require CO2/special media (Castaneda vented
bottles) and prolonged incubation (2-4 weeks) for growth. (Answer: all are true)
5. Usual acute bacterial
endocarditis (ABE) and prosthetic valve endocarditis (PVE) pathogens include:
a. S. aureus for ABE in normal hosts
b. S. aureus and P. aeruginosa for ABE in
IV drug abusers
c. S. viridans in early PVE
d. S. viridans and S. epidermidis in late
PVE
Make your selection before
scrolling down beyond this point
Answer: S. aureus is the most common cause
of ABE (in normal hosts and IV drug abusers), and is the most common cause of early PVE
(within 60 days of prosthetic valve replacement). S. aureus endocarditis is a severe
infection (esp. in non-addicts), affects normal and abnormal valves, and is associated
with multiple metastatic abscesses. S. viridans and S. epidermidis are common causes of
late PVE. S. viridans is a common cause of SBE and late PVE, but not early PVE. (Answer:
c)
6. Which of the following
statements about acute bacterial endocarditis are true:
a.
Methicillin-sensitive S. aureus (MSSA)
endocarditis in normal hosts can be effectively treated with IV naficillin or meropenem or
imipenem
b. ABE should be treated for 2-4 weeks in
normal hosts and 4-6 weeks in IV drug abusers
c. Tricuspid valve endocarditis is more
common in IV drug abusers than normal hosts, and is often associated with multiple septic
emboli
d. Janeway lesions
(nontender hemorrhagic
lesions of the palms and soles), splenomegaly, and clubbing are more common in ABE than
SBE
e. Teichoic acid antibody levels should be
followed weekly in S. aureus ABE, and fall (along with the ESR) with effective therapy
f. Premature closure of the anterior mitral
leaflet is an early sign of impending mitral valve regurgitation
Make your selection before
scrolling down beyond this point
Answer: Patients with ABE are critically
ill with high fever (except in some elderly patients or those with severe heart failure or
renal failure) and cardiac vegetations. Due to the fulminant nature of ABE, a baseline
echocardiogram should be obtained to watch for/identify valve destruction, heart failure,
and ring/perivalvular abscesses; premature closure of the mitral valve leaflet signifies
impending aortic valve regurgitation. Preferred IV therapy for ABE due to MSSA consists of
a 4-6 weeks of nafcillin 2 gm (IV) q4h or meropenem 1 gm (IV) q8h or imipenem 1 gm (IV)
q6h. ABE and PVE require a minimum of 4 weeks of antibiotic therapy. S. aureus ABE should
be followed with weekly teichoic acid antibody levels, which fall along with the ESR with
effective therapy. Janeway lesions (caused by septic embolic) are usually seen in ABE,
whereas splenomegaly, clubbing of the fingers, and petechiae are more common in
SBE. More
than 70% of IV drug abusers with right-sided (tricuspid valve) endocarditis have
associated septic pulmonary emboli mimicking pneumonia. Compared to S. aureus endocarditis
in non-addicts, S. aureus endocarditis in IV drug abusers is usually less severe and
associated with a better prognosis if not complicated by abscess, valve regurgitation, or
heart failure. (Answer: a, c, e)
7. Which of the following
statements about prosthetic valve endocarditis (PVE) are true:
a. Valve removal is always necessary for
cure of early and late PVE
b. In late
PVE, culture of the removed
valve may be negative, but valve gram stain is usually positive
c. PVE is equally common after replacement
of a non-infected or infected native valve
d. Most cases of late PVE occur 6-12 months
post-operatively
e. The mortality rate for early PVE is
higher than late PVE
Make your selection before
scrolling down beyond this point
Answer: Patients with early PVE improve
clinically on treatment, but are not cured without valve replacement. Valve removal may be
necessary for late PVE due to S. epidermidis, but is not always required. Culture of the
removed valve may be negative, but valve gram stain is usually positive. Late PVE usually
presents 18-24 months after valve replacement, and occurs more commonly after replacement
of an infected native valve than a non-infected valve (4% vs. 0.5% per patient-year),
although not necessarily with the original pathogen. Early PVE resembles ABE, and is a
more serious infection than late PVE, manifesting a more fulminant course and high
mortality rates (~ 30%); late PVE resembles S. viridans SBE clinically. (Answer:
b, e)
8. Endocarditis prophylaxis is:
a. Directed against S. viridans from the
mouth for above-the-waist procedures
b. Directed against Enterococci for
below-the-waist procedures
c. Fully protective is given properly
d. Preferred via the parenteral route for
patients with previous endocarditis, shunts, or rheumatic valve disease
Make your selection before
scrolling down beyond this point
Answer: Endocarditis prophylaxis is
designed to prevent native/prosthetic cardiac valve infections by preventing
procedure-related bacteremias due to cardiac pathogens. For procedures above-the-waist,
usual pathogens are viridans streptococci from the mouth. For procedures below-the-waist,
usual pathogens are enterococci. Since procedure-related bacteremias are usually
asymptomatic and last less than 15 minutes, single-dose oral regimens prior to the
procedure usually provide effective prophylaxis. Parenteral SBE prophylaxis is preferred
for patients with previous endocarditis, shunts, or prosthetic heart valves. Regimens vary
among the experts, and no regimen is fully protective. (Answer: a, b)
9. Which of the following
patient-procedure combinations require endocarditis prophylaxis:
a. Patient with ostium primum atrial septal
defect (ASD) undergoing Cesarean section
b. Patient with previous rheumatic fever
without valve disease undergoing cholecystectomy
c. Patient with previous endocarditis
undergoing flexible bronchoscopy with biopsy
d. Patient with MVP with valvular
regurgitation undergoing urethral catheterization in the presence of a UTI
Make your selection before
scrolling down beyond this point
Answer: Endocarditis prophylaxis is
indicated for patients with cardiac conditions in Column A undergoing procedures in Column
A in the table below. Prophylaxis is not recommended for patients or procedures in Column
B. (Answer: d)
Table.
Indications for Infective Endocarditis (IE) Prophylaxis |
Subset |
Prophylaxis
Recommended
(Column A) |
Prophylaxis
Not Recommended
(Column B) |
Cardiac conditions |
Ostium primum ASD
Prosthetic heart valves, including
bioprosthetic and homograft valves
Previous infective endocarditis
Most congenital cardiac malformations
Rheumatic valve disease
Hypertrophic cardiomyopathy
MVP with valvular regurgitation |
Isolated ostium
secundum ASD
Surgical repair without residue beyond 6
months of ostium secundum ASD or PDA
Previous coronary artery bypass surgery
MVP without valvular regurgitation
Physiologic, functional, or innocent murmurs
Previous Kawasaki's cardiac disease or
rheumatic fever without valve disease |
Procedures |
Dental procedures
known to induce gingival/mucosal bleeding, including dental cleaning
Tonsillectomy or adenoidectomy
Surgical operations involving intestinal or
respiratory mucosa
Rigid bronchoscopy
Sclerotherapy for esophageal varices
Esophageal dilation
Gallbladder surgery
Cystoscopy or urethral dilation
Urethral catheterization or urinary tract
surgery if UTI is present
Prostate surgery
I & D of infected tissue
Vaginal hysterectomy
Vaginal delivery, D & C, IUD
insertion/removal, or therapeutic abortion in the presence of infection |
Dental procedures
not likely to induce gingival bleeding
Tympanostomy tube insertion
Flexible bronchoscopy with or without biopsy
Endotracheal intubation
Endoscopy " gastrointestinal biopsy
Cesarean section
D & C, IUD insertion/removal, or
therapeutic abortion in the absence of infection
Cardiac pacemaker/defibrillator insertion
Coronary stent implantation
Percutaneous transluminal coronary angioplasty
(PTCA)
Cardiac catheterization |
10. Appropriate endocarditis
prophylaxis regimens include:
a. Above-the-waist procedures: Amoxicillin
1 gm (PO) 1 hour preprocedure
b. Above-the-waist procedures, prior
anaphylactic reaction to penicillin: Cephalexin 1 gm (PO) 1 hour preprocedure
c. Below-the-waist procedures: Amoxicillin
2 gm (PO) 1 hour preprocedure
d. Below-the-waist procedures, prior
endocarditis: Amoxicillin 2 gm (PO) 1 hour preprocedure
Make your selection before
scrolling down beyond this point
Answer: a, c (see Tables 1 and 2, below)
Table 1.
Endocarditis Prophylaxis for Above-the-Waist (Dental, Oral, Esophageal, Respiratory Tract)
Procedures* |
Prophylaxis** |
Reaction to Penicillin |
Antibiotic Regimen |
Oral
prophylaxis
|
None |
Amoxicillin 2 gm (PO) 1 hour
pre-procedure+ |
Non-anaphylactoid |
Cephalexin 1 gm (PO) 1 hour
pre-procedure |
Anaphylactoid |
Clindamycin 300 mg (PO) 1 hour
pre-procedure++ |
IV
prophylaxis
|
None |
Ampicillin 2 gm (IV) 30
minutes pre-procedure |
Non-anaphylactoid |
Cefazolin 1 gm (IV) 15 minutes
pre-procedure |
Anaphylactoid |
Clindamycin 600 mg (IV) 30
minutes pre-procedure |
* Endocarditis prophylaxis is directed against Streptococcus
viridans, the
usual SBE pathogen above the waist. Macrolide regimens are less effective than other
regimens; clarithromycin/azithromycin regimens (500 mg PO 1 hour pre-procedure) are of
unproven efficacy
** Oral prophylaxis is preferred to
IV prophylaxis, except in patients with previous endocarditis, shunts, or prosthetic heart
valves
+ Some recommend a 3 gm dose of
amoxicillin, which is excessive given the sensitivity of viridans streptococci to
amoxicillin
++ Some recommend a 600 mg dose of
clindamycin, but a 300 mg dose gives adequate blood levels and is better tolerated (less
diarrhea)
|
Table 2.
Endocarditis Prophylaxis for Below-the-Waist (Genitourinary, Gastrointestinal) Procedures* |
Prophylaxis** |
Reaction to Penicillin |
Antibiotic Regimen |
Oral
prophylaxis
|
None |
Amoxicillin 2 gm (PO) 1 hour
pre-procedure |
Non-anaphylactoid,
anaphylactoid |
Linezolid 600 mg
(PO) 1 hour pre-procedure |
IV
prophylaxis
|
None |
Ampicillin 2 gm (IV) 30
minutes pre-procedure
plus
Gentamicin 80 mg (IM or IV) over 1 hour 60 minutes pre-procedure |
Non-anaphylactoid,
anaphylactoid |
Vancomycin 1 gm (IV) over 1
hour 60 minutes pre-procedure
plus
Gentamicin 80 mg (IM or IV) over 1 hour 60 minutes pre-procedure |
* Endocarditis prophylaxis is directed against Enterococcus
faecalis, the
usual SBE pathogen below the waist
** Oral prophylaxis is preferred to
IV prophylaxis, except in patients with previous endocarditis, shunts, or prosthetic heart
valves
|
| ENDOCARDITIS PITFALLS |
PITFALL:
USE OF CONVENTIONAL DOSES OF BETA-LACTAMS FOR
STREP VIRIDANS SBE
Due to the extreme sensitivity of viridans streptococci to
beta-lactams, some clinicians use conventional doses of beta-lactams (e.g. penicillin G)
to treat S. viridans SBE. Nevertheless, high (endocarditis) doses of antibiotics (e.g.,
penicillin G 2-4 million units IV q4h) are recommended to penetrate cardiac vegetations
and ensure organisms under the fibrin blanket of the vegetation are eradicated. |
PITFALL:
EXCESSIVE DOSING OF GENTAMICIN FOR STREP VIRIDANS SBE
Synergy between gentamicin and
beta-lactams is useful to
decrease treatment duration without increasing relapse rates, but is no more effective at
eradicating S. viridans SBE than treatment with a beta-lactam alone for 4 weeks. Two weeks
of beta-lactam monotherapy is as efficacious as 4 weeks of therapy, but is associated with
a higher relapse rate and is therefore not recommended. When used for synergy, the dose of
aminoglycosides in less (usually ~ ½) than the usual monotherapy dose. Gentamicin has no
action against streptococci when used alone. |
PITFALL:
USE OF VANCOMYCIN ALONE FOR ENTEROCOCCAL ENDOCARDITIS IN PENICILLIN-ALLERGIC
PATIENTS
Bactericidal antibiotics are preferred for the treatment of
endocarditis. For penicillin-tolerant patients, the usual treatment of enterococcol (E.
faecalis) endocarditis is ampicillin plus gentamicin. For penicillin-allergic patients,
vancomycin alone is inadequate, since it is bacteriostatic (not bactericidal) against E.
faecalis. Vancomycin is, however, highly effective when combined with
gentamicin.
Alternatively, linezolid, imipenem, or meropenem could be used to treat E. faecalis SBE in
penicillin-allergic patients. |
| ARCHIVES |
|
The
other archives can be reached by returning to the Antibiotic
Self-Assessment page and clicking on the individual links there.
|
|